Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Haarmann-Stemmann

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Experimental Dermatology|April 26, 2013
Role of the aryl hydrocarbon receptor in tobacco smoke extract-induced matrix metalloproteinase-1 expressionYuko Ono, Kan Torii, Ellen Fritsche, et al.
Frontiers in Toxicology|March 17, 2022
Aryl Hydrocarbon Receptor Signaling Synergizes with TLR/NF-κB-Signaling for Induction of IL-22 Through Canonical and Non-Canonical AhR PathwaysYasuhiro Ishihara, Sarah Y Kado, Keith J Bein, et al.
Angewandte Chemie (International Ed. in English)|October 13, 2020
Extended Multicomponent Reactions with Indole Aldehydes: Access to Unprecedented Polyheterocyclic Scaffolds, Ligands of the Aryl Hydrocarbon ReceptorOuldouz Ghashghaei, Marina Pedrola, Francesca Seghetti, et al.
Cancers|May 1, 2019
A Protective Role of Aryl Hydrocarbon Receptor Repressor in Inflammation and Tumor GrowthChristoph F A Vogel, Yasuhiro Ishihara, Claire E Campbell, et al.
Archives of Toxicology|August 2, 2014
Activation of the aryl hydrocarbon receptor by the widely used Src family kinase inhibitor 4-amino-5-(4-chlorophenyl)-7-(dimethylethyl)pyrazolo[3,4-d]pyrimidine (PP2)Katrin Frauenstein, Julia Tigges, Anatoly A Soshilov, et al.
Archives of Toxicology|May 22, 2019
The Toll-like receptor agonist imiquimod is metabolized by aryl hydrocarbon receptor-regulated cytochrome P450 enzymes in human keratinocytes and mouse liverMelina Mescher, Julia Tigges, Katharina M Rolfes, et al.
The Journal of Investigative Dermatology|September 7, 2012
Aryl hydrocarbon receptor repressor (AhRR) function revisited: repression of CYP1 activity in human skin fibroblasts is not related to AhRR expressionJulia Tigges, Heike Weighardt, Sandra Wolff, et al.
Small (Weinheim an Der Bergstrasse, Germany)|December 23, 2020
Stem Cells for Next Level Toxicity Testing in the 21st CenturyEllen Fritsche, Thomas Haarmann-Stemmann, Julia Kapr, et al.
The Journal of Investigative Dermatology|September 3, 2013
The new aryl hydrocarbon receptor antagonist E/Z-2-benzylindene-5,6-dimethoxy-3,3-dimethylindan-1-one protects against UVB-induced signal transductionJulia Tigges, Thomas Haarmann-Stemmann, Christoph F A Vogel, et al.
Redox Biology|August 21, 2021
Inhibition of 6-formylindolo[3,2-b]carbazole metabolism sensitizes keratinocytes to UVA-induced apoptosis: Implications for vemurafenib-induced phototoxicityKatharina M Rolfes, Natalie C Sondermann, Christian Vogeley, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Experimental Dermatology|April 26, 2013
Role of the aryl hydrocarbon receptor in tobacco smoke extract-induced matrix metalloproteinase-1 expressionYuko Ono, Kan Torii, Ellen Fritsche, et al.
Frontiers in Toxicology|March 17, 2022
Aryl Hydrocarbon Receptor Signaling Synergizes with TLR/NF-κB-Signaling for Induction of IL-22 Through Canonical and Non-Canonical AhR PathwaysYasuhiro Ishihara, Sarah Y Kado, Keith J Bein, et al.
Angewandte Chemie (International Ed. in English)|October 13, 2020
Extended Multicomponent Reactions with Indole Aldehydes: Access to Unprecedented Polyheterocyclic Scaffolds, Ligands of the Aryl Hydrocarbon ReceptorOuldouz Ghashghaei, Marina Pedrola, Francesca Seghetti, et al.
Cancers|May 1, 2019
A Protective Role of Aryl Hydrocarbon Receptor Repressor in Inflammation and Tumor GrowthChristoph F A Vogel, Yasuhiro Ishihara, Claire E Campbell, et al.
Archives of Toxicology|August 2, 2014
Activation of the aryl hydrocarbon receptor by the widely used Src family kinase inhibitor 4-amino-5-(4-chlorophenyl)-7-(dimethylethyl)pyrazolo[3,4-d]pyrimidine (PP2)Katrin Frauenstein, Julia Tigges, Anatoly A Soshilov, et al.
Archives of Toxicology|May 22, 2019
The Toll-like receptor agonist imiquimod is metabolized by aryl hydrocarbon receptor-regulated cytochrome P450 enzymes in human keratinocytes and mouse liverMelina Mescher, Julia Tigges, Katharina M Rolfes, et al.
The Journal of Investigative Dermatology|September 7, 2012
Aryl hydrocarbon receptor repressor (AhRR) function revisited: repression of CYP1 activity in human skin fibroblasts is not related to AhRR expressionJulia Tigges, Heike Weighardt, Sandra Wolff, et al.
Small (Weinheim an Der Bergstrasse, Germany)|December 23, 2020
Stem Cells for Next Level Toxicity Testing in the 21st CenturyEllen Fritsche, Thomas Haarmann-Stemmann, Julia Kapr, et al.
The Journal of Investigative Dermatology|September 3, 2013
The new aryl hydrocarbon receptor antagonist E/Z-2-benzylindene-5,6-dimethoxy-3,3-dimethylindan-1-one protects against UVB-induced signal transductionJulia Tigges, Thomas Haarmann-Stemmann, Christoph F A Vogel, et al.
Redox Biology|August 21, 2021
Inhibition of 6-formylindolo[3,2-b]carbazole metabolism sensitizes keratinocytes to UVA-induced apoptosis: Implications for vemurafenib-induced phototoxicityKatharina M Rolfes, Natalie C Sondermann, Christian Vogeley, et al.
Pageof 8